INTERVIEW: EU industry calls for specialized, not special, notified bodies
This article was originally published in Clinica
Executive Summary
The EU medtech industry is calling for notified bodies who audit innovative and high-risk devices to specialize in specific medical domains, a measure that goes beyond what have been proposed so far by either the European Commission or Parliament. This specialization would address the demands of a sector that spans a wide range of technologies used in a broad scope of medical applications and carry a variety of potential risks.
You may also be interested in...
EU Regulatory Roundup, March 2024: Busy Agenda In Broad Range Of Key Areas
March was an important month for EU medtech regulation with an interesting spread of news relating to the Medical Device and IVD Regulations, the Batteries Regulation, the Artificial Intelligence Act and more.
EU’s Revised Phthalates Guideline Features New Annexes Focused On Alternatives
The effects of phthalates, plasticizers used in many medical devices, on the human endocrine system, have long been debated. But how safe are the alternatives? Updated guidelines give more insight.
Non-Medical Brain Stimulation Devices: Could They Be Down-Classified Again In the EU?
Six types of products that do not have an intended medical purpose fall under the scope of the Medical Device Regulation. Understanding their risks is complex and subject to regular re-examination by the European Commission.